Researchers are excited about the medication , a innovative dual agonist showing remarkable data in initial trials for size reduction . It acts by targeting two hormones : GLP-1 and GIP, these, when https://alexiamxig914859.blog-a-story.com/22512529/this-new-possibility-for-body-management